ࡱ>  g2ɀ\p Tracy Safran Ba==K+/!*8X@"1Arial1Arial1Arial1Arial1Arial1Arial1Calibri1 Calibri1Calibri14Calibri1 Calibri1Calibri1Calibri1,8Calibri18Calibri18Calibri1>Calibri14Calibri1<Calibri1?Calibri1h8Cambria1Calibri1 Calibri"$"#,##0_);\("$"#,##0\)!"$"#,##0_);[Red]\("$"#,##0\)""$"#,##0.00_);\("$"#,##0.00\)'""$"#,##0.00_);[Red]\("$"#,##0.00\)7*2_("$"* #,##0_);_("$"* \(#,##0\);_("$"* "-"_);_(@_).))_(* #,##0_);_(* \(#,##0\);_(* "-"_);_(@_)?,:_("$"* #,##0.00_);_("$"* \(#,##0.00\);_("$"* "-"??_);_(@_)6+1_(* #,##0.00_);_(* \(#,##0.00\);_(* "-"??_);_(@_)                                                                      ff + ) , *     P  P        `            a>     H) ||@&W}A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef;_(@_) }A} 00\);_(*ef ;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L;_(@_) }A} 00\);_(*L ;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A} 00\);_(*23;_(@_) }A}  00\);_(*23;_(@_) }A}! 00\);_(*23 ;_(@_) }A}" 00\);_(*;_(@_) }A}# 00\);_(*;_(@_) }A}$ 00\);_(*;_(@_) }A}% 00\);_(*;_(@_) }A}& 00\);_(*;_(@_) }A}' 00\);_(* ;_(@_) }A}( 00\);_(*;_(@_) }}) }00\);_(*;_(@_)    }}* 00\);_(*;_(@_) ??? ??? ??? ???}-}/ 00\);_(*}A}0 a00\);_(*;_(@_) }A}1 00\);_(*;_(@_) }A}2 00\);_(*?;_(@_) }A}3 00\);_(*23;_(@_) }-}4 00\);_(*}}5 ??v00\);_(*̙;_(@_)    }A}6 }00\);_(*;_(@_) }A}7 e00\);_(*;_(@_) }x}800\);_(*;_(  }}9 ???00\);_(*;_(??? ???  ??? ???}-}; 00\);_(*}U}< 00\);_(*;_( }-}= 00\);_(* 20% - Accent1M 20% - Accent1 ef % 20% - Accent2M" 20% - Accent2 ef % 20% - Accent3M& 20% - Accent3 ef % 20% - Accent4M* 20% - Accent4 ef % 20% - Accent5M. 20% - Accent5 ef % 20% - Accent6M2 20% - Accent6  ef % 40% - Accent1M 40% - Accent1 L % 40% - Accent2M# 40% - Accent2 L渷 % 40% - Accent3M' 40% - Accent3 L % 40% - Accent4M+ 40% - Accent4 L % 40% - Accent5M/ 40% - Accent5 L % 40% - Accent6M3 40% - Accent6  Lմ % 60% - Accent1M 60% - Accent1 23 % 60% - Accent2M$ 60% - Accent2 23ږ % 60% - Accent3M( 60% - Accent3 23כ % 60% - Accent4M, 60% - Accent4 23 % 60% - Accent5M0 60% - Accent5 23 %! 60% - Accent6M4 60% - Accent6  23 % "Accent1AAccent1 O % #Accent2A!Accent2 PM % $Accent3A%Accent3 Y % %Accent4A)Accent4 d % &Accent5A-Accent5 K % 'Accent6A1Accent6  F %(Bad9Bad  %) Calculation Calculation  }% * Check Cell Check Cell  %????????? ???+ Comma,( Comma [0]-&Currency.. Currency [0]/Explanatory TextG5Explanatory Text % 0Good;Good  a%1 Heading 1G Heading 1 I}%O2 Heading 2G Heading 2 I}%?3 Heading 3G Heading 3 I}%234 Heading 49 Heading 4 I}% 5InputuInput ̙ ??v% 6 Linked CellK Linked Cell }% 7NeutralANeutral  e%"Normal 8Noteb Note   9OutputwOutput  ???%????????? ???:$Percent ;Title1Title I}% <TotalMTotal %OO= Warning Text? Warning Text %XTableStyleMedium9PivotStyleLight16`MechanismOfAction  NDF-RT Code NDF-RT Name N000002002514-alpha Demethylase Inhibitors N00000001265-alpha Reductase Inhibitors N00001759555-Lipoxygenase Inhibitors N0000010218 N0000010219 N0000000183(Acetyl Aldehyde Dehydrogenase Inhibitors N0000175770 Acetylcholine Release Inhibitors N0000009955&Acetylcholine Transporter Interactions N0000000226Acid-Base Activity N0000175833Acidifying Activity N0000000072Active Transporter Interactions N0000000187Adenosine Deaminase Inhibitors N0000010334)Adenosine Diphosphate Receptor Inhibitors N0000175788Adenosine Receptor Agonists N0000175789Adenosine Receptor Antagonists N0000175787Adenosine Receptor Interactions N0000020044ADH Receptor Antagonists N0000000135 N0000175921$Adrenal Steroid Synthesis Inhibitors N0000000122Adrenergic Agonists N0000000209Adrenergic alpha-Agonists N0000000099Adrenergic alpha-Antagonists N0000009917Adrenergic alpha1-Agonists N0000009919Adrenergic alpha1-Antagonists N0000009918Adrenergic alpha2-Agonists N0000009920Adrenergic alpha2-Antagonists N0000000092Adrenergic Antagonists N0000000245Adrenergic beta-Agonists N0000000161Adrenergic beta-Antagonists N0000009921Adrenergic beta1-Agonists N0000009923Adrenergic beta1-Antagonists N0000009922Adrenergic beta2-Agonists N0000009924Adrenergic beta2-Antagonists N0000000153 Adrenergic Receptor Interactions N0000000179 Alcohol Dehydrogenase Inhibitors N0000011310Aldosterone Antagonists N0000009986Alkalinizing Activity N0000000236Alkylating Activity N0000000166alpha Glucosidase Inhibitors N0000175806Ammonium Ion Binding Activity N0000020016AMPA Receptor Antagonists N0000010274Amylase Inhibitors N0000020064Amylin Agonists N0000000146Androgen Receptor Agonists N0000000243Androgen Receptor Antagonists N0000175925Androgen Synthesis Inhibitors N0000000070"Angiotensin 2 Receptor Antagonists N0000000181(Angiotensin-converting Enzyme Inhibitors N0000010226Antibody Interactions N0000175985Antibody-Antibody Interactions N0000009949Antibody-Receptor Interactions N0000020023%Antibody-Surface Protein Interactions N0000009945 Antidiuretic Hormone Antagonists N0000009960Antithrombin Activators N0000175636 N0000000107 Antithrombins N0000175080Aromatase Inhibitors N00000002153ATP-Binding Cassette (ABC) Transporter Interactions N0000020009"Bcr-Abl Tyrosine Kinase Inhibitors N0000000202beta Lactamase Inhibitors N0000010260 N0000175365Bile-acid Binding Activity N0000175355Binding Activity N0000000142"Biological Macromolecular Activity N0000000247Biological Response Modifiers N0000009958 N0000175411'BRAF Serine/Threonine Kinase Inhibitors N0000175458Calcineurin Inhibitors N0000000259Calcium Channel Agonists N0000000069Calcium Channel Antagonists N0000000140Calcium Channel Interactions N0000175089Calcium Chelating Activity N0000020080%Calcium-Sensing Receptor Interactions N0000000235Carbonic Anhydrase Inhibitors N0000175756'Catechol O-Methyltransferase Inhibitors N0000175361"Catecholamine Synthesis Inhibitors N0000175856$CD11a-directed Antibody Interactions N0000175857"CD2-directed Antibody Interactions N0000175078#CD20-directed Antibody Interactions N0000177911#CD25-directed Receptor Interactions N0000175618CD3 Receptor Agonists N0000175619CD3 Receptor Antagonists N0000010281CD3 Receptor Interactions N0000175617"CD3-directed Antibody Interactions N0000175077#CD33-directed Antibody Interactions N0000175079#CD52-directed Antibody Interactions N0000009954)Cell Membrane Fusion Complex Interactions N0000000223"Cellular or Molecular Interactions N0000010255(Cellular Structure Molecule Interactions N0000000087Chelating Activity N0000175445#Chemokine Co-receptor 5 Antagonists N0000175444$Chemokine Co-receptor 5 Interactions N0000175456Chloride Channel Activators N0000000078Chloride Channel Agonists N0000000224Chloride Channel Antagonists N0000000156Chloride Channel Interactions N0000175919 Cholesterol Synthesis Inhibitors N0000175369Cholinergic Agonists N0000175370Cholinergic Antagonists N0000175652)Cholinergic Ganglionic Nicotinic Agonists N0000175653,Cholinergic Ganglionic Nicotinic Antagonists N0000175368Cholinergic Interactions N0000000104Cholinergic Muscarinic Agonists N0000000125"Cholinergic Muscarinic Antagonists N0000000097,Cholinergic Muscarinic Receptor Interactions N0000175717,Cholinergic Neuromuscular Nicotinic Agonists N0000175718/Cholinergic Neuromuscular Nicotinic Antagonists N0000000143Cholinergic Nicotinic Agonists N0000000227!Cholinergic Nicotinic Antagonists N0000000199+Cholinergic Nicotinic Receptor Interactions N0000000177Cholinesterase Inhibitors N0000000080Cholinesterase Reactivators N0000020036=Colony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors N0000175703-Competitive Cholinergic Nicotinic Antagonists N0000175686Competitive Opioid Antagonists N0000000086Complement 1 Inactivators N0000175441Complement 5 Inactivators N0000000192Complement Inactivators N0000175974Complement Inhibitors N0000020075Copper Chelating Activity N0000175450(Corticosteroid Hormone Receptor Agonists N0000008288 N0000000160Cyclooxygenase Inhibitors N0000000101Cysteine Proteinase Inhibitors N0000175549Cystine Disulfide Reduction N0000000175*Cytokine Receptor Superfamily Interactions N0000175844Decarboxylase Inhibitors N0000020082 N0000175532Demulcent Activity N0000009959Dephosphorylation Inhibitors N0000000191"Dihydrofolate Reductase Inhibitors N0000175513Dipeptidase Inhibitors N0000175912!Dipeptidyl Peptidase 4 Inhibitors N0000175548Disulfide Reduction N0000020086DNA Gyrase Inhibitors N0000019995 DNA Methyltransferase Inhibitors N0000020060DNA Polymerase Inhibitors N0000175755DOPA Decarboxylase Inhibitors N0000000117Dopamine Agonists N0000000230Dopamine Antagonists N0000175799Dopamine D2 Antagonists N0000000203Dopamine Receptor Interactions N0000000219!Dopamine Transporter Interactions N0000000114Dopamine Uptake Inhibitors N0000175533Dyes N0000020085 N0000000220Electrolyte Activity N0000175363Endothelin Receptor Agonists N0000175364Endothelin Receptor Antagonists N0000175362 Endothelin Receptor Interactions N0000000195Enkephalinase Inhibitors N0000000178Enzymatic Activity N0000000231Enzyme Activators N0000000133Enzyme Inhibitors N0000000163Enzyme Interactions N0000000208Enzyme Reactivators N0000009957Ergosterol Synthesis Inhibitors N0000011319Estradiol Antagonists N0000000100Estrogen Receptor Agonists N0000000145Estrogen Receptor Antagonists N0000000186Estrogen Receptor Modulators N0000175926Estrogen Synthesis Inhibitors N0000000232Excitatory Amino Acid Agonists N0000000088!Excitatory Amino Acid Antagonists N0000000171+Excitatory Amino Acid Receptor Interactions N0000175635Factor Xa Inhibitors N0000000111 Folic Acid Metabolism Inhibitors N0000000170 N0000175701#Full Cholinergic Nicotinic Agonists N0000175684Full Opioid Agonists N0000175615Fusion Protein Inhibitors N0000175614Fusion Protein Interactions N0000000152&G-Protein-linked Receptor Interactions N0000000196GABA A Agonists N0000000074GABA A Antagonists N0000000118GABA A Modulators N0000000138GABA A Receptor Interactions N0000000116GABA B Agonists N0000000229GABA B Antagonists N0000000251GABA B Modulators N0000000204GABA B Receptor Interactions N0000175868gamma-Ray Emitting Activity N0000010275 N0000020058(Glucagon-like Peptide-1 (GLP-1) Agonists N0000020059+Glucagon-like Peptide-1 (GLP-1) Antagonists N00000200575Glucagon-like Peptide-1 (GLP-1) Receptor Interactions N0000020027Glucan Synthase Inhibitors< N0000000159 Glucocorticoid Receptor Agonists N0000000110#Glucocorticoid Receptor Antagonists N0000175923#Glucocorticoid Synthesis Inhibitors N0000020018Glucosyl Transferase Inhibitors N0000020019$Glucosylceramide Synthase Inhibitors N0000000073Glycine Agonists N0000000119Glycine Antagonists N0000000244Glycine Receptor Interactions N00001756540Gonadotropin Releasing Hormone Receptor Agonists N00001750843Gonadotropin Releasing Hormone Receptor Antagonists N0000010266 Growth Hormone Receptor Agonists N0000010267#Growth Hormone Receptor Antagonists N0000000252GTP Phosphohydrolase Activators N0000175981Heparin Binding Activity N0000020006HER Receptor Family Antagonists N0000000067 HER Receptor Family Interactions N0000020010HER1 Antagonists N0000020008HER2/Neu/cerbB2 Antagonists N0000020012HER3 Antagonists N0000000112Histamine Agonists N0000000207 N0000000190 N0000000151 N0000000216Histamine Receptor Interactions N0000175071Histone Deacetylase Inhibitors N0000000127HIV Integrase Inhibitors N0000000246HIV Protease Inhibitors N0000000149Hormone Receptor Agonists N0000000221Hormone Receptor Antagonists N0000000257Hormone Receptor Interactions N0000000255Hormone Receptor Modulators N0000000121.Hydroxymethylglutaryl-CoA Reductase Inhibitors N0000175808,Hydroxyphenylpyruvate Dioxygenase Inhibitors N0000019993&Hypothalamic Hormone Receptor Agonists N0000019994)Hypothalamic Hormone Receptor Antagonists N0000019992 Hypothalmic Hormone Interactions N0000175792"IgE-directed Antibody Interactions N0000000137 IGF Type 1 Receptor Interactions N0000010257Imaging Contrast Activity N0000000254"Immunologic and Biological Factors N0000000082Immunologic Factors N0000020081 N0000000225Insulin Receptor Agonists N0000000071Insulin Receptor Antagonists N0000000240Insulin Receptor Interactions N0000000258Integrase Inhibitors N0000175774Integrin Receptor Antagonists N0000175773Integrin Receptor Interactions N0000000157Interferon Inducers N0000175708Interleukin 1 Receptor Agonists N0000175709"Interleukin 1 Receptor Antagonists N0000175707#Interleukin 1 Receptor Interactions N0000010280Interleukin 2 Receptor Agonists N0000010279"Interleukin 2 Receptor Antagonists N0000010278#Interleukin 2 Receptor Interactions N00001756215Interleukin 2 Receptor-directed Antibody Interactions N0000010276Iodide Peroxidase Inhibitors N0000000193Ion Channel Interactions N0000175356Ion Exchange Activity N0000020014)Ionotropic Glutamate Receptor Antagonists N0000000144Iron Chelating Activity N0000175534 Irrigation N0000020017Kainate Receptor Antagonists N0000020071,Keratinocyte Growth Factor Receptor Agonists N0000020072/Keratinocyte Growth Factor Receptor Antagonists N00000200700Keratinocyte Growth Factor Receptor Interactions N0000175082Kinase Inhibitors N0000020065&L-Calcium Channel Receptor Antagonists N0000175962Lead Chelating Activity N0000000083 Leukotriene Receptor Antagonists N0000000124!Leukotriene Receptor Interactions N0000009916Lipase Inhibitors N0000000134Lipoxygenase Inhibitors N0000175542M2 Protein Inhibitors N0000000081:Macrophage Colony Stimulating Factor Receptor Interactions N0000175834Magnesium Ion Exchange Activity N0000175862$Magnetic Resonance Contrast Activity N0000175850Melanin Synthesis Inhibitors N0000000250Melatonin Receptor Agonists N0000000123Melatonin Receptor Interactions N0000175472Metal Chelating Activity N0000175804Methylating Activity N0000000094#Mineralocorticoid Receptor Agonists N0000000139&Mineralocorticoid Receptor Antagonists N0000175924&Mineralocorticoid Synthesis Inhibitors N0000000184Monoamine Oxidase Inhibitors N0000175760Monoamine Oxidase-A Inhibitors N0000175761Monoamine Oxidase-B Inhibitors N0000175624mTOR Inhibitors N0000020069&N-Calcium Channel Receptor Antagonists N0000000238Na-K ATPases Interactions N0000175436Neuraminidase Inhibitors N0000010262Neurokinin 1 Antagonists N0000010261"Neurokinin 1 Receptor Interactions N0000000105)Neurotransmitter Transporter Interactions N0000020037-Neurotrophic Factor Receptor (RET) Inhibitors N0000000120Nitric Oxide Donors N0000000173 Nitric Oxide Synthase Inhibitors N0000020015NMDA Receptor Antagonists N0000009948/Non-Nucleoside Reverse Transcriptase Inhibitors N00001757040Noncompetitive Cholinergic Nicotinic Antagonists N0000175687!Noncompetitive Opioid Antagonists N0000000234'Norepinephrine Transporter Interactions N0000000102 Norepinephrine Uptake Inhibitors N0000000233!Nucleic Acid Synthesis Inhibitors N0000009947+Nucleoside Reverse Transcriptase Inhibitors N0000175074Nucleoside Synthesis Inhibitors N0000000174Opioid Agonists N0000000154Opioid Antagonists N0000000200Opioid Receptor Interactions N0000000132&Organic Anion Transporter Interactions N0000010288Osmotic Activity N0000175546Oxidation Activity N0000175545Oxidation-Reduction Activity N0000000239P-Glycoprotein Interactions N0000009946 N0000000158Parathormone Receptor Agonists N0000000136!Parathormone Receptor Antagonists N0000000068"Parathormone Receptor Interactions N0000175702&Partial Cholinergic Nicotinic Agonists N0000175685Partial Opioid Agonists N0000175374 N0000175375 N0000175376 N0000175378 N0000175377 N0000020074Phosphate Chelating Activity N0000175086Phosphodiesterase 3 Inhibitors N0000020026Phosphodiesterase 5 Inhibitors N0000000128Phosphodiesterase Inhibitors N0000010217Photoabsorption N0000000065Physiochemical Activity N0000000165#Pituitary Hormone Receptor Agonists N0000000249&Pituitary Hormone Receptor Antagonists N0000000141(Pituitary Hormones Receptor Interactions N0000010264Plasmin Inhibitors N0000000089Plasminogen Activators N0000009961%Platelet Activating Factor Inhibitors N0000009962)Platelet Glycoprotein IIb/IIIA Inhibitors N0000020028 N0000000093 N0000020029 N0000000189 N0000020030 N0000020076Plutonium Chelating Activity N0000000253!Polycationic Channel Interactions N0000175869Positron Emitting Activity N0000175449Potassium Channel Agonists N0000175448Potassium Channel Antagonists N0000000211Potassium Channel Interactions N0000178377Potassium Ion Binding Activity N0000175357Potassium Ion Exchange Activity N0000000185(Progestational Hormone Receptor Agonists N0000000115+Progestational Hormone Receptor Antagonists N0000175927Progestin Synthesis Inhibitors N0000020068Prostacyclin Receptor Agonists N0000000106Prostaglandin Receptor Agonists N0000000108"Prostaglandin Receptor Antagonists N0000000131#Prostaglandin Receptor Interactions N0000000076Protease Inhibitors N0000175075Proteasome Inhibitors N0000175076Protein Kinase Inhibitors N0000000150Protein Synthesis Inhibitors N0000000147Proton Pump Inhibitors N0000000205Radiopharmaceutical Activity N0000020062,Receptor Activity Modifying Protein Agonists N0000020061$Receptor Activity Modifying Proteins N0000020063 N0000000085Receptor Interactions N0000000213$Receptor Protein Kinase Interactions N0000020000#Receptor Tyrosine Kinase Inhibitors N0000175547Reduction Activity N0000175899Renin Inhibitors N0000000103 Reverse Transcriptase Inhibitors N0000000212#Ribonucleotide Reductase Inhibitors N0000175516RNA Synthetase Inhibitors N0000020024Sclerosing Activity N0000020078Secretin Receptor Agonists N0000020079Secretin Receptor Antagonists N0000020077Secretin Receptor Interactions N0000000168&Selective Estrogen Receptor Modulators N0000000169Serine Proteinase Inhibitors N0000175763Serotonin 1b Receptor Agonists N0000175764Serotonin 1d Receptor Agonists N0000175817 Serotonin 3 Receptor Antagonists N0000175816 Serotonin 4< Receptor Antagonists N0000000188Serotonin 5HT-3 Agonists N0000000090Serotonin 5HT-3 Antagonists N0000000095%Serotonin 5HT-3 Receptor Interactions N0000000256Serotonin Agonists N0000000130Serotonin Antagonists N0000000198Serotonin Receptor Interactions N0000000167"Serotonin Transporter Interactions N0000000109Serotonin Uptake Inhibitors N0000000214Sex Hormone Receptor Agonists N0000000084 Sex Hormone Receptor Antagonists N0000175922 Sex Hormone Synthesis Inhibitors N0000000066%Small Ion Transport Pump Interactions N0000000180Sodium Channel Interactions N0000000194Somatostatin Receptor Agonists N0000000218"Somatostatin Receptor Interactions N0000000217Somatotropin Receptor Agonists N0000000077"Somatotropin Receptor Interactions N0000010265!Squalene Monooxygenase Inhibitors N0000020034*Stem Cell Factor (KIT) Receptor Inhibitors N0000000182!Steroid Hormone Receptor Agonists N0000000162Steroid Receptor Antagonists N0000000172Steroid Receptor Modulators N0000175920Steroid Synthesis Inhibitors N0000009956Sterol Synthesis Inhibitors N0000000075Stool Bulking Activity N0000000228Structural Macromolecules N0000009983Sulfate Donors N0000000079Surfactant Activity N0000009953$Synaptic Fusion Complex Interactions N0000020066&T-Calcium Channel Receptor Antagonists N0000009963Thrombin Inhibitors N0000175968 Thrombopoietin Receptor Agonists N0000175967$Thrombopoietin Receptor Interactions N0000000098!Thymidylate Synthetase Inhibitors N0000000237!Thyroid Hormone Receptor Agonists N0000000222$Thyroid Hormone Receptor Antagonists N0000175917$Thyroid Hormone Synthesis Inhibitors N0000010263'Tissue Plasminogen Activator Inhibitors N0000000241Tissue Plasminogen Activators N0000175890Topoisomerase 1 Inhibitors N0000020088Topoisomerase 2 Inhibitors N0000020087Topoisomerase 4 Inhibitors N0000000176Topoisomerase Inhibitors N0000000242Transcription Factor Activity N0000010215Transpeptidase Inhibitors N0000000197Trypsin Inhibitors N0000010256 N0000175446 N0000175447 N00001754510Tumor Necrosis Factor Receptor Blocking Activity N0000009950+Tumor Necrosis Factor Receptor Interactions N0000020001Tyrosine Kinase Inhibitors N0000020084Ubiquitin Ligase Inhibitors N0000010259Ultrasound Contrast Activity N0000000155 Uncouplers N0000009915)Unknown Cellular or Molecular Interaction N0000175087Urease Inhibitors N00000200076Vascular Endothelial Growth Factor Receptor Inhibitors N0000178291AVascular Endothelial Growth Factor-directed Antibody Interactions N0000020031VEGFR1 Inhibitors N0000020032VEGFR2 Inhibitors N0000020033VEGFR3 Inhibitors N0000178333+Vesicular Monoamine Transporter Antagonists N0000178332,Vesicular Monoamine Transporter Interactions N0000020089 N0000000164&Vitamin K Epoxide Reductase Inhibitors N0000175964Vitamin K Inhibitors N00000200672Voltage-gated Calcium Channel Receptor Antagonists N0000010258X-Ray Contrast Activity N0000000206Xanthine Oxidase Inhibitors N0000180999)Angiotensin 2 Type 1 Receptor AntagonistsAntithrombin 3 Activatorsbeta Tubulin InteractionsBone Surface Interactions N0000181008Cannabinoid Receptor Agonists N0000181009 Cannabinoid Receptor Antagonists N0000181007!Cannabinoid Receptor InteractionsCyclooxygenase 2 Inhibitors.Decreased Calcium-sensing Receptor SensitivityE3 Ubiquitin Ligase Inhibitors N0000181000 Fatty Acid Synthetase Inhibitors Free Radical Scavenging ActivityGlucagon Receptor Interactions!Histamine H1 Receptor Antagonists!Histamine H2 Receptor Antagonists N0000181003!Histamine H3 Receptor AntagonistsHistamine Receptor Antagonists N0000181002HIV Fusion Protein InhibitorsImmunologic Adjuvants.Increased Calcium-sensing Receptor Sensitivity N0000181010Ionophoric Activity!Para-Aminobenzoic Acid Inhibitors3Peroxisome Proliferator-activated Receptor Activity9Peroxisome Proliferator-activated Receptor alpha Agonists8Peroxisome Proliferator-activated Receptor beta Agonists9Peroxisome Proliferator-activated Receptor delta Agonists9Peroxisome Proliferator-activated Receptor gamma Agonists8Platelet-derived Growth Factor alpha Receptor Inhibitors:Platelet-derived Growth Factor alpha Receptor Interactions7Platelet-derived Growth Factor beta Receptor Inhibitors9Platelet-derived Growth Factor beta Receptor Interactions2Platelet-derived Growth Factor Receptor Inhibitors/Receptor Activity Modifying Protein Antagonists N0000181001#Siderophore Iron Chelating Activity N0000181004Sodium Channel Antagonists N0000181005$Sodium Chloride Symporter Inhibitors N0000181006.Sodium Potassium Chloride Symporter InhibitorsTubulin Interactions6Tumor Necrosis Factor alpha Receptor Blocking Activity5Tumor Necrosis Factor beta Receptor Blocking Activity"Ultraviolet A Radiation Absorption"Ultraviolet B Radiation AbsorptionViral Envelope Interactions N0000181817%Competitive NMDA Receptor Antagonists N0000181812&Lysophospholipid Receptor Interactions N0000181813&Lysosphingolipid Receptor Interactions N0000181820!NMDA Receptor Glycine Antagonists N0000181818(Noncompetitive NMDA Receptor Antagonists N0000181814-Sphingosine 1-Phosphate Receptor Interactions N0000181815+Sphingosine 1-Phosphate Receptor Modulators N0000181819'Uncompetitive NMDA Receptor Antagonists N0000182150#CD80-directed Antibody Interactions N0000182151#CD86-directed Antibody Interactions N0000182138Cytochrome P450 1A2 Inhibitors N0000182139Cytochrome P450 2B6 Inhibitors N0000182140Cytochrome P450 2C19 Inhibitors N0000182137Cytochrome P450 2D6 Inhibitors N0000182141Cytochrome P450 3A4 Inhibitors N0000182136Cytochrome P450 Inhibitors N0000182143P2Y12 Receptor Antagonists N0000182145Sigma Receptor Interactions N0000182147Sigma-1 Receptor Agonists N0000182148Sigma-1 Receptor Antagonists N0000182146Sigma-1 Receptor Interactions N00001826366B Lymphocyte Stimulator-directed Antibody Interactions N0000182634%CTLA-4-directed Antibody Interactions N0000182632Cytochrome P450 17A1 Inhibitors N0000182638HCV NS3/4A Protease Inhibitors N0000182728Potassium Channel Openers N0000182727Sodium Channel Agonists N0000185009Serotonin 2c Receptor Agonists N0000182960Phosphodiesterase 4 Inhibitors N0000184142Ligase Activators N0000182966#CD30-directed Antibody Interactions N0000184012!Endogenous Antigen Neutralization N0000182964"Bradykinin B2 Receptor Antagonists N0000185007Adrenergic beta3-Agonists N0000184150Digoxin Binding Activity N0000184145(Chloride Channel Activation Potentiators N0000184151Kallikrein Inhibitors N0000184141#Bacterial Neurotoxin Neutralization N0000184008Antigen Neutralization N0000184009Virus Neutralization N0000184010Venom Neutralization N0000184143+Carbamoyl Phosphate Synthetase 1 Activators N0000182963Bradykinin Receptor Antagonists N0000184148Smoothened Receptor Antagonists N0000182962 Bradykinin Receptor Interactions N0000184147 Smoothened Receptor Interactions N0000184011Bacterial Toxin Neutralization N0000185507Cytochrome P450 2C9 Inducers N0000185504Cytochrome P450 2C9 Inhibitors N0000185506Cytochrome P450 3A4 Inducers N0000185505Cytochrome P450 Inducers N0000185501-Dihydroorotate Dehydrogenase Inhibitors [MoA] N0000185499Guanylate Cyclase Activators N0000185498Lyase Activators N0000185503P-Glycoprotein Inhibitors N0000185607Cytochrome P450 2C19 Inducers ) *r+=,Z,-.P/m0201a2~-3J 3 4 p5 J6g +7H 789:q;H<eT=qD>a?$?@YAvB;BoC;DXDE|F9GVGH]IzeJi-K1'L+LMXN\OP"PQmRqBSF 7T; T U V W `XdBYFYZ[\]L^P_ _y`}CaG bbckdoZe^ffgshwHiLj jkloamAKn+oopqmHr(ss t u vvV ^w> bxBoyOz|}~ĀkY9C#؄qQQ1"ccB g2ɀ P4|Ġ T,tL$l  dMbP?_*+%&?'?(?)?"B??01&U} m } 9>      ? ? l m : ; g h     ! "          # $            d ! "   [ \       Y Z   k [ a b   # $    Dl !"#$%&'()*+,-./0123456789:;<=>?   !c !d " " # # $ $ %R %S &T &U 'V 'W ( ( )X )Y *O *v +E +F ,9 ,: -g -h .u .v /s /t 0) 0* 1i 1j 2 2 3 3 4i 4j 5 5 6 6 7' 7( 8 8 9 9 : : ;I ;J <G <H =G =H > > ?y ?zDl@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_ @ @ AK AL BI BJ C C D  D  E E Ft Fu G G H H I I J" Jr Kw Kx L L M M N% N& O? O@ P P QS QT R R S S T' T( U) U* V+ V, W- W. X/ X0 Y1 Y2 Z= Z> [? [@ \A \B ] ] ^ ^ _E _FDl`abcdefghijklmnopqrstuvwxyz{|}~ `3 `4 ay az b b cA cB d d eE eF f3 f4 g g h h i i j j k k l l m m n n o o p p q q r r s s t t u u v v w w xZ x[ y\ y] z^ z_ { { |` |a } } ~5 ~6 7 8Dl 9 : ; < = > ? @   w x       S T  s  e p q   < =                                  Dl           _ `   ~            H I V W   1 2         U V 8 9             C D          Dl   b c   @ A B C N  ] ^     ' ( ' (       p q     K L   w x y | z } { ~ |      }       k  l m n g hDl   k l                     m n         o p       e f + ,     % &   % & + ,      Dl         ) * q r Q R D E F G H I   n o   > ?                          - . M N c d _ ` -    a b M N  Dl !"#$%&'()*+,-./0123456789:;<=>?   ! ! " " # # $O $P %Q %R &4 &5 ' ' (t (u )6 )7 * * +{ +| , , - - . .  /J /K 0L 0M 1 1 2 2 3 3 4 4 5. 5 6/ 6 70 71 82 83 9 9 : : ; ; < < = = > > ? ?Dl@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_ @ @ A A B B C C D D E E F F GJ GK HX HY I I J3 J4 K K L L MW MX N N O O P) P* Q+ Q, R R S S T T U U V V W W X X Y Y Z Z [ [ \ \ ] ] ^ ^ _e _fDl`abcdefghijklmnopqrstuvwxyz{|}~ `g `h ai aj b b c c d d e e f f g  g  h h iZ iw j[ jx k\ ky l] lz m^ m{ n n o o pL pM qe qf rN rO s s t t u u v v wG wi x x y/ y0 z  z {5 {6 | | }U }V ~ ~ P QDl m n                      ^ _         o p R S   7 8    o   W X - . O P    !   ! "    Dl   ` a               T U         P Q A B   C D         { |   d j       # $      Dl   b c               9 :                 } ~     } ~ ; < / 0   # $      ] u v k l  Dl   1 2 = >         q r   Y Z ; <           s t   % &     5 6   v \     r s  f 7 8     C DDl>@A   7ggD Oh+'0p08 P \hTracy Safran@^sL@01y՜.+,0HP X`hp x  MechanismOfAction  Worksheets  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxy{|}~Root Entry FWorkbook;SummaryInformation(zDocumentSummaryInformation8